As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...
Dozens of unexpected genes are strongly linked to type 2 diabetes, new research from The Jackson Laboratory (JAX) shows. The ...
Quarterly RNA drug plozasiran turns off a liver gene, sharply lowering life‑threatening pancreatitis attacks in a rare ...
A medical oncologist called the late-stage clinical trial results “remarkable,” though Sasse said the drug means his body ...
An investigational targeted therapy doubled survival compared with standard chemotherapy for pretreated individuals with ...
Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a ...
A drug trial at Northwestern Medicine offers hopeful results to those with pancreatic cancer. GI Oncologist Dr. Deva ...
RenovoRx, Inc., which is developing targeted oncology therapies and commercializing its FDA-cleared RenovoCath drug-delivery devi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results